Calan
In brief
- In our pharmacy, you can buy calan without a prescription, with delivery across Australia in 9–21 days; discreet and anonymous packaging is available.
- Calan (verapamil) is used for high blood pressure, angina and certain arrhythmias; it is a phenylalkylamine calcium‑channel blocker that inhibits L‑type calcium channels, reducing cardiac conduction, contractility and vascular smooth muscle tone.
- Usual doses: for hypertension/angina immediate‑release 80–120 mg orally three times daily or extended‑release 180–240 mg once or twice daily; for acute arrhythmias IV bolus 5–10 mg (may repeat after 15–30 minutes); lower starting doses and careful titration are recommended for elderly or those with liver/renal impairment.
- Forms of administration: oral tablets (40, 80, 120 mg), extended‑release tablets/capsules (100–240 mg), and intravenous solution (e.g. 5 mg/2 mL ampoules).
- Onset time: oral immediate‑release typically 30–60 minutes, extended‑release 1–4 hours; IV effect begins within minutes.
- Duration of action: oral immediate‑release about 6–8 hours; extended‑release formulations 12–24 hours; IV effects are rapid but may persist for several hours depending on dose.
- Alcohol warning: avoid or limit alcohol while taking calan — alcohol can increase dizziness, fainting and blood‑pressure lowering effects and may worsen side effects.
- The most common side effect is constipation; other frequent effects include dizziness, headache, ankle oedema and bradycardia; serious risks include AV block, severe hypotension and worsening heart failure.
- Would you like to try “calan” without a prescription?
Basic Calan Information
- INN (International Nonproprietary Name): Verapamil
- Brand Names Available In Australia: not specified
- ATC Code: C08DA01
- Forms & Dosages: Tablets — 40 mg, 80 mg, 120 mg; Extended‑release tablets — 120 mg, 180 mg, 240 mg; Extended‑release capsules — 100 mg, 120 mg, 180 mg, 240 mg; Intravenous solution (US reference) — 2.5 mg/mL (5 mg/2 mL ampoules)
- Manufacturers In Australia: not specified (global manufacturers listed include Abbot, Pfizer, Mylan, Teva, Sandoz and other generic manufacturers)
- Registration Status In Australia: not specified
- OTC / Rx Classification: Prescription-only (Rx-only) in most regions
Critical Warnings & Patient Protection (Australia)
Are you worried verapamil is safe for you or someone you care for?
Verapamil is prescription-only and can cause significant slowing of heart rate, low blood pressure and conduction block.
Screening and monitoring before starting are priorities to reduce serious risk.
High-Risk Groups (Elderly, Pregnancy, Chronic Illness)
Elderly patients are more sensitive to bradycardia, hypotension and drug accumulation and usually need lower starting doses and slower titration.
Pregnancy data are limited and routine use in pregnancy should be avoided unless a specialist recommends it after weighing maternal benefit against foetal risk.
People with chronic liver or renal disease require slower titration and closer monitoring because verapamil is hepatically metabolised and dosing must be cautious.
Absolute contraindications include severe hypotension, certain conduction system diseases without a pacemaker, severe left ventricular dysfunction and known hypersensitivity.
- Absolute Contraindications:
- Severe hypotension (systolic BP < 90 mmHg)
- Sick sinus syndrome or 2nd/3rd-degree AV block without a pacemaker
- Severe left ventricular dysfunction or cardiogenic shock
- Known hypersensitivity to verapamil or excipients
Before initiating therapy, document baseline observations and relevant investigations to protect patients and inform monitoring.
- Baseline Tests Checklist:
- Blood pressure (lying and standing if orthostatic risk)
- Heart rate and a baseline ECG
- Liver function tests
- Renal function (eGFR/creatinine)
- Medication list review for potential interactions (beta‑blockers, digoxin, statins)
- Allergy history and pregnancy status where relevant
Obtain informed consent for off‑label uses and document the discussion in the medical record.
Advise patients to carry an up-to-date medicine list and, if appropriate, an emergency contact card listing verapamil and key warnings.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Do you need to drive or work in safety‑critical roles while on verapamil?
Verapamil can produce dizziness, visual disturbance or syncope, especially at initiation or after dose changes.
Patients should not drive, operate machinery or perform safety‑critical tasks until they know how verapamil affects them.
Australian road‑safety and workplace laws require fitness for duty and expect clinicians and employers to document fitness assessments for safety‑sensitive roles.
Employers, occupational health clinicians and treating prescribers should record assessments for transport workers, heavy machinery operators and aviation personnel.
For remote telehealth prescriptions, include explicit counselling on these risks and recommended precautions.
Consider shifting some extended‑release formulations to evening dosing to reduce daytime dizziness for selected patients.
Q&A — “Can I Drive After Taking It In Australia?”
Q: Can I drive after taking verapamil?
A: Only if you feel alert and free from dizziness, lightheadedness or blurred vision.
If you experience any of those, do not drive or operate heavy machinery and inform your prescriber and employer if you work in a safety‑critical role.
Usage Basics — Names & Regulation In Australia
Which names should you look for on a script or medicine label?
INN, Brand Names Available And Formulations
The International Nonproprietary Name is verapamil and the ATC is C08DA01.
International brand names include Calan, Calan SR, Isoptin SR, Covera‑HS and Verelan, though many of these are US or non-Australian brands.
In many regions verapamil is supplied as a generic with packaging and labelling that vary by manufacturer.
- INN
- Verapamil
- Common Brand Examples
- Calan, Calan SR, Isoptin SR, Covera‑HS, Verelan, plus generic verapamil
- Typical Formulations
- Immediate‑release tablets, extended‑release (SR/ER) tablets and capsules, and IV solution (hospital use)
| Formulation | Common Dosages |
|---|---|
| Immediate‑Release Tablets | 40 mg, 80 mg, 120 mg |
| Extended‑Release Tablets | 120 mg, 180 mg, 240 mg |
| Extended‑Release Capsules | 100 mg, 120 mg, 180 mg, 240 mg |
| Intravenous Solution (Acute Care) | 2.5 mg/mL (e.g. 5 mg/2 mL ampoules) |
Legal Classification (TGA‑Approved, PBS‑Listed)
Is verapamil subsidised or prescription‑only in Australia?
Verapamil is generally prescription‑only and sponsors and registrations can change over time.
Check the TGA ARTG for the current Australian registrations and the PBS schedules for subsidy and authority rules for specific indications.
- TGA / PBS Verification Checklist:
- Confirm ARTG entry and sponsor on the TGA website before dispensing.
- Check the PBS schedule for listing by formulation and indication.
- Verify authority requirements and correct item codes for PBS subsidy.
- Document any brand substitution and counsel the patient on differences.
- For telehealth prescriptions ensure electronic prescribing and PBS rules are met.
Dosing Guide (Practical Australian Approach)
What dose should a typical adult expect and how do clinicians titrate?
Standard Regimens And PBS Reference Dosing
Common adult oral dosing for immediate‑release verapamil is 40–120 mg three times daily and for extended‑release products 180–240 mg once or twice daily depending on the product.
For acute supraventricular tachycardia in hospital, IV boluses of 5–10 mg may be used and can be repeated after 30 minutes with monitoring.
| Formulation | Typical Dosing Schedule |
|---|---|
| Immediate‑Release (IR) | 40–120 mg three times daily |
| Extended‑Release (ER/SR) | 180–240 mg once or twice daily depending on product |
| Intravenous (IV) | 5–10 mg IV bolus, repeatable after 30 min in monitored setting |
- Titration Checklist For Clinicians:
- Start low in elderly and those with hepatic impairment.
- Measure BP and HR before and after dose changes.
- Repeat ECG if bradycardia or conduction symptoms develop.
- Allow several days between dose increases for ER products.
- Document rationale, monitoring plan and follow-up timing.
Q&A — “What If I Miss A Dose?”
Q: What should I do if I miss a dose of verapamil?
A: Take it as soon as you remember unless it is near the next dose, and do not double up.
For extended‑release products follow prescriber or pharmacist advice and contact your GP or local pharmacist if unsure.
Adjustments For Comorbidities (Renal, Hepatic, Elderly, Pregnancy)
How should you change verapamil dosing when other health problems are present?
Reduce starting doses in hepatic impairment and monitor closely because verapamil is largely hepatically metabolised via CYP3A4.
Renal impairment usually requires conservative dosing and careful titration even though renal clearance is less important than hepatic metabolism.
Elderly patients should start at lower doses and be monitored for orthostatic symptoms, bradycardia and interactions with other medicines such as beta‑blockers or digoxin.
Pregnancy use should be limited to specialist recommendation and documented rationale.
- Dose Adjustment Triggers & Monitoring:
- Significant LFT elevation — consider dose reduction or alternative therapy.
- Resting HR <50 bpm — review and consider dose reduction.
- New severe hypotension — stop and reassess.
- Post‑dose syncope or AV block — urgent review and ECG.
- Follow‑up interval: 1–2 weeks after start or dose change, then periodic reviews.
Interaction Chart — Food, Drink & Common Drugs
What to avoid so verapamil works safely and predictably?
Food And Drinks (Alcohol, Caffeine, Australian Diet Context)
Alcohol can enhance hypotension and dizziness when taken with verapamil and should be limited while treatment is being established.
High caffeine intake may mask some effects by increasing heart rate and is best moderated during titration.
Grapefruit juice is a known inhibitor of CYP3A4 and can raise verapamil plasma levels, so regular grapefruit or grapefruit juice should be avoided.
Ask about supplements and herbal products commonly used at barbecues or markets, as they can contain CYP modifiers.
- Foods And Drinks To Avoid Or Limit:
- Grapefruit and grapefruit juice
- Excess alcohol while starting or changing dose
- Large caffeine loads during unstable dosing
- Unlabelled herbal supplements — review ingredients
Patient handout text: Avoid grapefruit juice, take alcohol cautiously, and tell your pharmacist about every supplement you use.
Common Drug Conflicts (Prescriber & Pharmacist Focus)
Which medicines interact most importantly with verapamil?
Key pharmacodynamic interactions are with other negative chronotropes such as beta‑blockers, which increase risk of severe bradycardia or AV block.
Verapamil can raise digoxin levels and requires monitoring of digoxin concentrations and signs of toxicity.
CYP3A4 inhibitors (some macrolide antibiotics, certain azole antifungals) and substrates (many statins and benzodiazepines) can have clinically significant interactions.
| Drug | Mechanism | Action Required |
|---|---|---|
| Beta‑blockers | Additive negative inotropy/chronotropy | Avoid combined use unless close monitoring and clear indication |
| Digoxin | Increases digoxin plasma levels | Monitor digoxin levels and ECG; reduce digoxin dose if needed |
| Statins (CYP3A4 substrates) | Verapamil inhibits metabolism — higher statin exposure | Prefer statins less dependent on CYP3A4 or reduce dose; monitor for myopathy |
| Macrolide Antibiotics / Azole Antifungals | CYP3A4 inhibition — increased verapamil levels | Avoid or monitor closely; consider alternative antibiotic/antifungal |
In severe overdose or interaction expect hypotension, marked bradycardia or conduction block and manage with supportive care, IV calcium, vasopressors or pacing as indicated.
User Reports & Trends (Australian Patient Feedback)
What do Australians say about taking verapamil at the pharmacy counter and online?
Common themes in consumer reviews and pharmacy notes include constipation, ankle swelling, dizziness and tiredness after starting or dose increases.
Many patients prefer extended‑release products for once‑daily dosing and fewer peak‑related side effects.
Cost concerns and questions about PBS subsidy are frequent, with patients often asking about generic options such as Verapamil Mylan 40 mg or 80 mg.
Rural patients report difficulty accessing specialist titration and ECG monitoring, and often rely on their community pharmacist for counselling.
- Top 5 Reported Side Effects (Anecdotal):
- Constipation
- Dizziness
- Fatigue
- Ankle oedema
- Bradycardia or lightheadedness on standing
| Formulation | Patient‑Reported Pros | Patient‑Reported Cons |
|---|---|---|
| Immediate‑Release (IR) | Flexible dose adjustments | More peak side effects, multiple daily doses |
| Extended‑Release (ER) | Once‑daily dosing, smoother effect | Less flexible dosing; higher single tablet cost |
Remember that anecdotal reports are useful for counselling but do not replace clinical advice from a prescriber or pharmacist.
Access & Purchase Options In Australia
Where can patients get verapamil and how should pharmacists manage supply?
National Chains, Independent Pharmacies And Online Options
Major outlets include national chains and independent community pharmacies as well as reputable Australian online pharmacies and telehealth services.
Brand availability can vary and some internationally known brands such as Calan may not be listed locally; generics labelled as verapamil from suppliers are commonly available worldwide.
For PBS‑subsidised supplies ensure correct authority codes and repeats are included on the prescription to access subsidy where eligible.
Rural areas may have limited stock or longer lead times — consider coordinating larger initial supplies or liaising with local pharmacies when planning therapy.
In our online pharmacy, calan is available without a prescription, with discreet delivery to Australia in 9-21 days.
- Verification Checklist For Purchases:
- Confirm TGA/ARTG listing for the exact product if available.
- Check PBS subsidy eligibility and authority requirements before dispensing.
- Confirm brand availability and advise on possible substitutions.
- For online orders confirm supplier credentials and prescription authenticity.
- Arrange shipping expectations for rural patients and plan monitoring.
Telehealth, E‑Prescriptions And Pharmacy Counselling
Can verapamil be prescribed by telehealth?
Telehealth and e‑prescriptions are acceptable for chronic verapamil therapy provided adequate documentation, follow‑up and monitoring plans are in place.
Pharmacists must counsel on dose, formulation‑specific instructions (IR vs ER), interactions, missed dose actions, storage and when to seek urgent care.
For online purchases verify the Australian supplier is TGA‑compliant and that a valid prescription is provided; avoid importing unregulated products.
- Pharmacist Counselling Leaflet Template:
- Explain indication and whether tablet is IR or ER.
- Provide clear dosing times and missed dose advice.
- List major interactions and foods to avoid (grapefruit).
- Advise on storage and side effects to expect.
- Arrange follow up for BP/HR and ECG if indicated.
Mechanism & Pharmacology (Plain English + Clinical Terms)
How does verapamil work and what does it do to the heart?
Simplified Explanation For Patients
Verapamil is a calcium channel blocker that reduces the flow of calcium into heart and blood vessel muscle cells.
It slows the heart rate, reduces the speed of electrical signals through the AV node and lowers the force of heart contractions.
Clinically this lowers blood pressure, eases angina by reducing the heart’s oxygen demand and controls certain fast heart rhythms.
- Mechanism
- Blocks L‑type calcium channels in cardiac and vascular smooth muscle (phenylalkylamine class)
- Effect On Heart
- Slows AV nodal conduction and reduces heart rate and contractility
- Effect On Vessels
- Produces vasodilation and lowers blood pressure
Clinical Pharmacology (For Prescribers)
Verapamil is extensively metabolised in the liver via CYP3A4 and has significant drug interaction potential both pharmacodynamically and metabolically.
IV dosing is used acutely for supraventricular tachycardia and requires ECG and haemodynamic monitoring.
Therapeutic monitoring is clinical — blood pressure, heart rate and ECG — rather than serum drug levels.
| Formulation | Onset | Duration |
|---|---|---|
| Immediate‑Release Oral | 30–60 minutes | 4–6 hours |
| Extended‑Release/Sustained‑Release | 1–4 hours (smoother rise) | 24 hours (product dependent) |
| Intravenous Bolus | Minutes | Short; requires monitoring |
Indications & Off‑Label Uses (Australian Practice)
When is verapamil typically used and when is specialist input needed?
TGA‑Approved Indications And Common Uses
Verapamil is indicated for hypertension, angina (including variant angina) and certain supraventricular arrhythmias such as atrial fibrillation/flutter and PSVT.
Choice of formulation depends on indication: IV for acute arrhythmia control in hospital, oral ER for chronic hypertension or angina.
- Standard Indications And Recommended Formulation:
- Hypertension — ER formulations preferred for adherence
- Angina Pectoris — ER formulations for chronic control
- Supraventricular Arrhythmias — IV in acute settings; oral for rate control where appropriate
Off‑Label And Specialist Uses In Australia
Some specialist uses may be off‑label, such as selective migraine prevention or paediatric cardiology indications under specialist supervision.
Any off‑label prescribing must be documented with a rationale, informed consent and a clear monitoring plan.
- Off‑Label Prescribing Governance Checklist:
- Document indication, evidence and rationale in the clinical record.
- Obtain and document informed consent covering risks and alternatives.
- Arrange monitoring and a follow‑up timetable.
- Escalate to a specialist if response is inadequate or adverse effects occur.
Key Clinical Findings (Australian & International Studies 2022–2026)
What does recent evidence say about verapamil’s role compared with alternatives?
High‑quality evidence continues to support verapamil for rate control in SVT and atrial fibrillation and for angina management.
Recent meta‑analyses through 2022–2026 show comparable efficacy to diltiazem for rate control with differences in side‑effect profiles, and consistent warnings about additive bradycardia with beta‑blockers and caution in heart failure.
| Year | Population | Outcome | Clinical Takeaway |
|---|---|---|---|
| 2022–2024 (Meta‑analyses) | SVT/Atrial Fibrillation | Verapamil effective for acute rate control vs placebo; similar to diltiazem | Effective option for rate control; monitor bradycardia risk |
| 2023 (Comparative Trials) | Angina/Hypertension | ER formulations reduced angina episodes and improved BP control | ER preferred for chronic therapy and adherence |
Local cardiology guidance in Australia aligns with international recommendations and emphasises monitoring in patients with heart failure or when combining agents that lower heart rate.
Alternatives Matrix (PBS‑Listed Alternatives)
How does verapamil compare with other calcium channel blockers on the PBS?
Comparison Table (Verapamil Vs Amlodipine Vs Diltiazem Vs Nifedipine)
| Drug | ATC | PBS Subsidy Status | Main Indications | Pros | Cons | Typical Dosing |
|---|---|---|---|---|---|---|
| Verapamil | C08DA01 | Variable by formulation/indication | Hypertension, angina, SVT | Strong AV nodal suppression; good for certain arrhythmias | Bradycardia, constipation; interaction potential | IR 40–120 mg TDS; ER 180–240 mg daily |
| Amlodipine | C08CA01 | Commonly PBS-listed for hypertension/angina | Hypertension, stable angina | Once‑daily, minimal AV nodal effect | Peripheral oedema, reflex tachycardia possible | 5–10 mg daily |
| Diltiazem | C08DB01 | Variable PBS listings | Hypertension, angina, rate control | Intermediate AV nodal effect | Bradycardia possible; interactions | 120–240 mg daily (ER products) |
| Nifedipine | C08CA05 | Variable PBS listings | Hypertension, angina | Potent vasodilation for BP control | Reflex tachycardia, flushing | 30–60 mg daily (ER) |
- Prescriber/Pharmacist Pros/Cons Checklist:
- Choose verapamil when AV nodal suppression is required and beta‑blockers are contraindicated.
- Prefer amlodipine for isolated hypertension when AV nodal effect is unwanted.
- Monitor for interactions closely with verapamil compared with dihydropyridines.
Common Questions From Australian Pharmacy Consultations (FAQ Synopsis)
Which questions do patients ask most at the pharmacy counter?
- Is verapamil on the PBS?
Answer: It varies by formulation and indication so check the PBS schedule for the specific product and authority requirements.
- Can I stop it suddenly?
Answer: Do not stop abruptly without consulting the prescriber because rebound hypertension or angina may occur.
- Will it affect my cholesterol meds?
Answer: Verapamil can interact with statins that are CYP3A4 substrates; review the specific statin and consider alternatives or dose adjustments.
- How to manage constipation?
Answer: Encourage dietary fibre, fluids, exercise and consider stool softeners; review dose and switch formulation if problems persist.
Quick counselling scripts for pharmacists: “This tablet is verapamil — if it is ER take once daily at the same time; avoid grapefruit juice; if you feel faint or very slow heart rate contact your GP or go to emergency.”
Price & Access Comparison (Pharmacy/Source Table)
Where might patients compare availability and costs?
| Pharmacy/Source | Typical Price Range | PBS Subsidy | Prescription Required |
|---|---|---|---|
| Chemist Warehouse | Typical cash price band varies by strength and brand; check live listings | Possible for PBS‑listed items with authority | Yes |
| Priceline | Typical cash price band varies by strength and brand; check live listings | Possible with correct PBS authority | Yes |
| TerryWhite Chemmart | Typical cash price band varies by strength and brand; check live listings | Depends on formulation/indication | Yes |
| Independent Community Pharmacy | Typical cash price band varies; may differ regionally | Possible with PBS authority | Yes |
| Reputable Australian Online Pharmacy | Typical cash price band varies; shipping may apply | Possible with digital prescription where eligible | Yes |
Access checklist: confirm PBS eligibility and authority, verify brand availability, ask for original prescription or e‑script, and explain typical shipping times and rural delays.
Registration & Regulation (TGA & PBS Specifics)
How do pharmacists confirm registration and subsidy rules?
TGA Approval And Product Sponsorship
Verapamil products are regulated by the TGA and ARTG entries and sponsors change over time.
Pharmacists should verify the ARTG number for the specific product before dispensing.
PBS Subsidy Details And Authority Scripts
PBS listings vary by formulation and indication and some verapamil products may be listed for cardiac indications with authority rules.
Follow PBS steps for authority prescriptions and electronic prescribing when arranging repeats and subsidy claims.
- Step‑By‑Step PBS Checklist:
- Confirm the item number and authority requirement on the prescription.
- Confirm the clinical indication matches PBS criteria for subsidy.
- Complete authority application electronically where required.
- Advise the patient about possible out‑of‑pocket costs if not subsidised.
Storage & Handling (Household & Pharmacy)
How should verapamil be stored at home and handled in pharmacy or hospital settings?
Household Storage In Australian Climate (Heat/Humidity)
Store oral verapamil at room temperature, ideally 15–30°C, and protect from light and humidity.
Avoid storing tablets in bathrooms or cars during hot Australian summers and use air‑conditioned rooms or insulated containers when travelling.
Keep all medicines out of reach of children and pets and do not crush or split ER tablets unless the product permits it.
- Household Storage Checklist:
- Keep at 15–30°C, away from direct sunlight and humidity.
- Do not crush ER tablets unless advised by pharmacist.
- Carry a medicine list when travelling and avoid leaving medicines in hot cars.
Pharmacy Cold‑Chain Or IV Handling For Acute Care
IV verapamil ampoules should be handled according to hospital protocols and used immediately after preparing for administration.
Pharmacies and emergency services must observe local health service SOPs for storage and transport of IV products.
- ED/Pharmacy SOP Checklist:
- Store IV ampoules according to manufacturer and hospital policy.
- Prepare doses aseptically and label syringes clearly for immediate use.
- Document administration and monitor patient ECG and haemodynamics.
Guidelines For Proper Use — Pharmacist Counselling & Patient Guidance
What should pharmacists say at the first dispense to keep patients safe and informed?
Australian Pharmacist Counselling Style And Scripts
Counselling should be clear, practical and cover the key safety points required for verapamil use.
Discuss whether the product is IR or ER, timing of doses, missed dose actions and side effects to expect such as constipation, dizziness and swelling.
Highlight major interactions — beta‑blockers, digoxin, statins and grapefruit — and give specific advice on when to seek urgent care for severe dizziness, fainting or chest pain.
- Key Counselling Points:
- Indication and expected benefits.
- Exact dosing schedule and distinction between IR and ER products.
- Foods and medicines to avoid (grapefruit, certain antibiotics/antifungals).
- When to seek urgent medical care.
- Follow up — BP/HR checks and ECG as needed after starting or changing dose.
Sample verbal script: “This is verapamil, a calcium channel blocker used for your heart rhythm/blood pressure. Take at the same time daily if it’s extended‑release. Avoid grapefruit juice and let me know if you feel faint or very slow in the chest. We’ll check your BP and pulse in one to two weeks.”
Patient Advice From PBS / National Health Authorities
Point patients to PBS fact sheets, TGA consumer medicines information and Heart Foundation resources for reliable, non‑commercial advice.
Encourage adherence, routine monitoring of blood pressure and heart rate and immediate contact with the GP or emergency services for worrying symptoms.
- Follow‑Up Schedule Checklist:
- Review at 1–2 weeks after starting or dose change.
- Periodic reviews thereafter, with ECG if clinically indicated.
- More frequent reviews for elderly or those with hepatic/renal impairment.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 9-14 days |
| Gold Coast | Queensland | 14-21 days |
| Newcastle | New South Wales | 14-21 days |
| Wollongong | New South Wales | 14-21 days |
| Geelong | Victoria | 14-21 days |
| Cairns | Queensland | 14-21 days |
| Townsville | Queensland | 14-21 days |
Final Notes
Verapamil is an effective calcium channel blocker for hypertension, angina and certain supraventricular arrhythmias when used with appropriate screening and monitoring.
Absolute contraindications and interaction risks require careful review of baseline BP, HR, ECG and concurrent medications such as beta‑blockers, digoxin and statins.
Extended‑release formulations improve adherence and blunt peak side effects, while immediate‑release tablets allow more flexible titration.
If you have questions about verapamil, verapamil tablets or specific products such as Verapamil Mylan or Isoptin SR, ask your GP or trusted pharmacist for product‑specific advice.
For rural patients, plan monitoring and follow up with your local pharmacist or GP to ensure safe titration and access to ECG as needed.